FI102516B1 - Förfarande för framställning av en kaseinfraktion med adhesionsinhiberande verkan på bakterier - Google Patents

Förfarande för framställning av en kaseinfraktion med adhesionsinhiberande verkan på bakterier

Info

Publication number
FI102516B1
FI102516B1 FI913154A FI913154A FI102516B1 FI 102516 B1 FI102516 B1 FI 102516B1 FI 913154 A FI913154 A FI 913154A FI 913154 A FI913154 A FI 913154A FI 102516 B1 FI102516 B1 FI 102516B1
Authority
FI
Finland
Prior art keywords
bacteria
preparing
inhibitory effect
adhesion inhibitory
casein fraction
Prior art date
Application number
FI913154A
Other languages
English (en)
Finnish (fi)
Other versions
FI913154A0 (fi
FI102516B (sv
Inventor
Bengt Andersson
Gustaf Aniansson
Ragnar Lindstedt
Eden Catharina Svanborg
Original Assignee
Bengt Andersson
Gustaf Aniansson
Ragnar Lindstedt
Eden Catharina Svanborg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Andersson, Gustaf Aniansson, Ragnar Lindstedt, Eden Catharina Svanborg filed Critical Bengt Andersson
Publication of FI913154A0 publication Critical patent/FI913154A0/fi
Application granted granted Critical
Publication of FI102516B1 publication Critical patent/FI102516B1/sv
Publication of FI102516B publication Critical patent/FI102516B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Catching Or Destruction (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
FI913154A 1989-10-30 1991-06-28 Förfarande för framställning av en kaseinfraktion med adhesionsinhiber ande verkan på bakterier FI102516B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition
PCT/SE1990/000702 WO1991006308A1 (en) 1989-10-30 1990-10-30 A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract

Publications (3)

Publication Number Publication Date
FI913154A0 FI913154A0 (fi) 1991-06-28
FI102516B1 true FI102516B1 (sv) 1998-12-31
FI102516B FI102516B (sv) 1998-12-31

Family

ID=20377332

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913154A FI102516B (sv) 1989-10-30 1991-06-28 Förfarande för framställning av en kaseinfraktion med adhesionsinhiber ande verkan på bakterier

Country Status (15)

Country Link
EP (1) EP0454813B1 (sv)
JP (1) JPH04503077A (sv)
KR (1) KR920700678A (sv)
AT (1) ATE170754T1 (sv)
AU (1) AU633647B2 (sv)
CA (1) CA2044244A1 (sv)
DE (1) DE69032646T2 (sv)
DK (1) DK0454813T3 (sv)
ES (1) ES2121755T3 (sv)
FI (1) FI102516B (sv)
HU (1) HU212935B (sv)
NO (1) NO912391L (sv)
RU (1) RU2035913C1 (sv)
SE (1) SE465109B (sv)
WO (1) WO1991006308A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538952A (en) * 1994-05-26 1996-07-23 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
US5506209A (en) * 1994-05-26 1996-04-09 Abbott Laboratories Product for inhibition of infection of mammalian cells by respiratory syncytial virus
US5707968A (en) * 1994-05-26 1998-01-13 Abbott Laboratories Inhibition of attachment of H.influenzae to human cells
EP0760674A1 (en) * 1994-05-26 1997-03-12 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
US5643880A (en) * 1994-05-26 1997-07-01 Abbott Laboratories Product for inhibition of attachment of H. influenzae to human cells
CA2190610A1 (en) * 1994-05-26 1995-12-07 Pradip Mukerji Inhibition of attachment of h. influenzae to human cells
US5942254A (en) * 1995-02-27 1999-08-24 Abbott Laboratories Phosphorylated recombinant human β-casein expressed in a bacterial system
WO1997026320A2 (en) * 1995-11-06 1997-07-24 Abbott Laboratories Product for inhibition of attachment of h. influenzae to human cells
NZ322369A (en) * 1995-11-06 1999-11-29 Abbott Lab Use of phosphorylated BETA H.influenzae
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
WO2004047778A1 (en) 2002-11-26 2004-06-10 Uc Tech Materials and methods for preventing and treating microbe-mediated epithelial disorders
BRPI0814412A2 (pt) 2007-07-06 2017-05-23 Laclede Inc uso de enzimas hidrolíticas e oxidativas para dissolver biofilme nas passagens das vias aéreas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496671A (en) * 1975-03-27 1977-12-30 Grindstedvaerket As Anti-cancer-active sour milk fraction
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2592769B1 (fr) * 1986-01-10 1990-10-12 Agronomique Inst Nat Rech Procede d'obtention d'une matiere enrichie en caseine beta, appareillage pour la mise en oeuvre de ce procede, et application des produits obtenus par ce procede comme aliments, complements alimentaires ou additifs en industrie alimentaire et pharmaceutique ou dans la preparation de peptides a activite physiologique
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤

Also Published As

Publication number Publication date
ES2121755T3 (es) 1998-12-16
ATE170754T1 (de) 1998-09-15
FI913154A0 (fi) 1991-06-28
SE8903625D0 (sv) 1989-10-30
KR920700678A (ko) 1992-08-10
DE69032646D1 (de) 1998-10-15
EP0454813A1 (en) 1991-11-06
EP0454813B1 (en) 1998-09-09
RU2035913C1 (ru) 1995-05-27
HU212935B (en) 1996-12-30
SE465109B (sv) 1991-07-29
AU6647090A (en) 1991-05-31
SE8903625L (sv) 1991-05-01
DK0454813T3 (da) 1999-02-01
AU633647B2 (en) 1993-02-04
FI102516B (sv) 1998-12-31
DE69032646T2 (de) 1999-05-27
CA2044244A1 (en) 1991-05-01
NO912391D0 (no) 1991-06-19
JPH04503077A (ja) 1992-06-04
WO1991006308A1 (en) 1991-05-16
NO912391L (no) 1991-06-19

Similar Documents

Publication Publication Date Title
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
FI102516B1 (sv) Förfarande för framställning av en kaseinfraktion med adhesionsinhiberande verkan på bakterier
WO2000039299A3 (en) Streptococcus antigens
EP1757697A3 (en) Group B streptococcus antigens
EP1731166A3 (en) Streptococcus pneumoniae proteins and vaccines
ATE112937T1 (de) Sterilfiltrierte kolostralmilch.
EP0376251A3 (en) An anticoagulant substance obtained from urine
MX9203629A (es) Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b.
CA2326148A1 (en) Method for providing glutamine
GB2126236B (en) Production of antibodies
CA2197659C (en) Antibacterial composition containing multimeric alpha-lactalbumin
WO1992021697A3 (en) Diagnostic peptides derived from m.tuberculosis antigens
NO883219D0 (no) Framgangsmaate for framstilling av beta-lactam-forbindelse, mellomprodukt for framstilling av denne, og medisinske sammensetninger for behandling av bakteriologiske infeksjonssykdommer inneholdende denne.
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
DE3560262D1 (en) Hexapeptide, process for its preparation and pharmaceutical compositions thereof
FR2705234B1 (fr) Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.
RU96121279A (ru) Способ лечения пародонтоза
CA2151945A1 (en) Assay and treatment for demyelinating diseases such as multiple sclerosis
EP1950302A3 (en) Streptococcus antigens
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.